M. Bontenbal - Concepedia

Author

M. Bontenbal

Rotterdam University of Applied Sciences

Also Known As

Bontenbal, M, M Bontenbal, M. BONTENBAL, M. Bontenbal, Marijke Bontenbal, S Rodenhuis, on behalf of the EORTC Breast Cancer Cooperative Group

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Rotterdam University of Applied Sciences Erasmus MC Cancer Institute The Netherlands Cancer Institute Radboud University Nijmegen Erasmus MC

About

M. Bontenbal is an author at Rotterdam University of Applied Sciences specializing in oncology, medicine, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	29	2.3K
2	Health Sciences	3	3	210
3	Nursing	3	3	75
4	Public Health	2	2	301
5	Cell Biology	2	2	44

M. Bontenbal

Publications

Citations

H-Index

Page 1

	Year	Citations
Risk of endometrial cancer after tamoxifen treatment of breast cancer Flora E. van Leeuwen, Alexandra W. van den Belt‐Dusebout, F.E. van Leeuwen, The Lancet Breast OncologyMedicineGynecologyBreast CancerOncology	1994	571
Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer. J.-M. Nabholtz, Karen A. Gelmon, M. Bontenbal, Journal of Clinical Oncology	1996	382
Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative Study Frédéric Amant, Gϋnter von Minckwitz, Sileny Han, Journal of Clinical Oncology	2013	365
Treatment of breast cancer during pregnancy: an observational study Sibylle Loibl, Sileny Han, Gϋnter von Minckwitz, The Lancet Oncology Breast OncologyMedicineGynecologyMaternal HealthPregnancy	2012	287
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer Sjoerd Rodenhuis, M. Bontenbal, L.V.A.M. Beex, New England Journal of Medicine	2003	259
Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. John A. Foekens, Manfred Schmitt, W L van Putten, PubMed UrologyBreast OncologyEndocrine-related CancerMedicinePrognostic Value	1992	231
Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer. Martine Piccart, J.G.M. Klijn, Robert Paridaens, Journal of Clinical Oncology	1997	158
Multimodality treatment for anaplastic thyroid carcinoma – Treatment outcome in 75 patients Annemarie T. Swaak‐Kragten, Johannes H.W. de Wilt, Paul Schmitz, Radiotherapy and Oncology MedicineMultimodality TherapyThyroid DiseaseMultimodalityCombined Modality Treatment	2009	130
Phase II to III Study Comparing Doxorubicin and Docetaxel With Fluorouracil, Doxorubicin, and Cyclophosphamide As First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer Centre M. Bontenbal, Geert‐Jan Creemers, Hans J. Braun, Journal of Clinical Oncology	2005	102
The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers Mieke Kriege, Agnes Jager, Maartje J. Hooning, Cancer	2011	94

Page 1